Home/Filings/4/0001213900-25-102764
4//SEC Filing

Kaplan Myron 4

Accession 0001213900-25-102764

CIK 0001410098other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 9:30 PM ET

Size

6.9 KB

Accession

0001213900-25-102764

Insider Transaction Report

Form 4
Period: 2025-10-23
Kaplan Myron
Director
Transactions
  • Purchase

    Common Stock

    2025-10-23$11.02/sh+25,000$275,500201,034 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    10,000
  • Common Stock

    (indirect: By Spouse)
    20,000
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.01 to $11.03, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001672645

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 9:30 PM ET
Size
6.9 KB